<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"
https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/ Neuraxpharm CHARLES MORRIS Charles Morris is Chief Corporate Development Officer and joined Neuraxpharm in January 2022. Charles is a seasoned M&A professional with 20 years of experience in investment banking and corporate M&A in the pharmaceutical industry, across multiple geographies, including the US, Germany and Spain. Before joining Neuraxpharm, Charles was Global Head of […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"class_list":["post-19900","page","type-page","status-publish","hentry"],"yoast_head":"\n
Charles Morris - Neuraxpharm SE<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n